Though conventional therapy aims to alleviate hypocalcemia and its symptoms, it does not restore normal PTH physiology and is associated with long-term complications including nephrocalcinosis, nephrolithiasis, and renal dysfunction (8). The gene discussed is PTH; the disease is nephrocalcinosis.